NASDAQ:NXGNNextgen Healthcare Stock Price, Forecast & News

$11.27

+0.32 (+2.92 %)

(As of 06/5/2020 04:00 PM ET)

Add

Compare

Today's Range

$10.69

Now: $11.27▼

$11.37

50-Day Range

$8.73

MA: $10.13▼

$11.42

52-Week Range

$5.10

Now: $11.27▼

$20.68

Volume393,100 shs

Average Volume408,014 shs

Market Capitalization$745.00 million

P/E Ratio93.92

Dividend YieldN/A

Beta0.96

NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based electronic health record and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile Health Solutions, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health and NextGen Share interoperability solutions. It also provides professional services, including training, project management, functional and detailed specification preparation, configuration, testing, installation, support, and client services. It serves physician hospital and management service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. NextGen Healthcare, Inc. has a strategic partnership with OTTO Health LLC. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was founded in 1974 and is headquartered in Irvine, California.

Beat the Market (BTM) Rank^™

2.0 Analyst's Opinion

Consensus Rating
Nextgen Healthcare has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on 2 buy ratings, 9 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $11.59, Nextgen Healthcare has a potential upside of 2.8% from its current price of $11.27.
Amount of Analyst Coverage
Nextgen Healthcare has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.1 Community Rank

Outperform Votes
Nextgen Healthcare has received 112 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Nextgen Healthcare has received 158 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Nextgen Healthcare has received 58.52% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Nextgen Healthcare and other stocks. Vote “Outperform” if you believe NXGN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NXGN will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Nextgen Healthcare does not currently pay a dividend.
Dividend Growth
Nextgen Healthcare does not have a long track record of dividend growth.

4.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nextgen Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $143,476.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 18.50% of the stock of Nextgen Healthcare is held by insiders.
Percentage Held by Institutions
73.70% of the stock of Nextgen Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Nextgen Healthcare are expected to grow by 29.27% in the coming year, from $0.41 to $0.53 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Nextgen Healthcare is 93.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.38.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nextgen Healthcare is 93.92, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.65.
Price to Earnings Growth Ratio
Nextgen Healthcare has a PEG Ratio of 4.41. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Nextgen Healthcare has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.88 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Computer integrated systems design

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:NXGN

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.nextgen.com

Phone949-255-2600

Debt

Debt-to-Equity Ratio0.42

Current Ratio1.82

Quick Ratio1.12

Price-To-Earnings

Trailing P/E Ratio93.92

Forward P/E Ratio27.49

P/E Growth4.41

Sales & Book Value

Annual Sales$540.24 million

Price / Sales1.38

Cash Flow$1.57 per share

Price / Cash Flow7.18

Book Value$5.81 per share

Price / Book1.94

Profitability

EPS (Most Recent Fiscal Year)$0.59

Net Income$24.49 million

Net Margins1.39%

Return on Equity9.98%

Return on Assets6.32%

Miscellaneous

Employees2,660

Outstanding Shares66,105,000

Market Cap$745.00 million

Next Earnings Date7/22/2020 (Estimated)

OptionableOptionable

Receive NXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for NXGN and its competitors with MarketBeat's FREE daily newsletter.

Nextgen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

How has Nextgen Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Nextgen Healthcare's stock was trading at $11.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NXGN shares have increased by 2.4% and is now trading at $11.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Nextgen Healthcare?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nextgen Healthcare in the last year. There are currently 1 sell rating, 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Nextgen Healthcare.

When is Nextgen Healthcare's next earnings date?

Nextgen Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Nextgen Healthcare.

How were Nextgen Healthcare's earnings last quarter?

Nextgen Healthcare Inc (NASDAQ:NXGN) released its quarterly earnings results on Monday, June, 1st. The company reported $0.20 EPS for the quarter, beating the Zacks' consensus estimate of $0.19 by $0.01. The firm had revenue of $136.38 million for the quarter, compared to analyst estimates of $136.07 million. Nextgen Healthcare had a return on equity of 9.98% and a net margin of 1.39%. The firm's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.23 EPS. View Nextgen Healthcare's earnings history.

What guidance has Nextgen Healthcare issued on next quarter's earnings?

Nextgen Healthcare issued an update on its fourth quarter earnings guidance on Monday, May, 4th. The company provided earnings per share guidance of $0.19-0.21 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.19. The company issued revenue guidance of $134-138 million, compared to the consensus revenue estimate of $138.42 million.

What price target have analysts set for NXGN?

12 brokers have issued 1 year target prices for Nextgen Healthcare's shares. Their forecasts range from $9.00 to $17.00. On average, they anticipate Nextgen Healthcare's stock price to reach $11.59 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price. View analysts' price targets for Nextgen Healthcare.

Has Nextgen Healthcare been receiving favorable news coverage?

Press coverage about NXGN stock has been trending negative this week, InfoTrie reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nextgen Healthcare earned a media sentiment score of -2.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutNextgen Healthcare.

Are investors shorting Nextgen Healthcare?

Nextgen Healthcare saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 877,000 shares, an increase of 8.4% from the April 30th total of 809,200 shares. Based on an average trading volume of 435,700 shares, the days-to-cover ratio is currently 2.0 days. Approximately 1.7% of the shares of the company are sold short. View Nextgen Healthcare's Current Options Chain.

Who are some of Nextgen Healthcare's key competitors?

Some companies that are related to Nextgen Healthcare include NetScout Systems (NTCT), Scientific Games (SGMS), Sykes Enterprises (SYKE), Allscripts Healthcare Solutions (MDRX), Simulations Plus (SLP), Onespan (OSPN), Ebix (EBIX), Unisys (UIS), Ribbon Communications (RBBN), Agilysys (AGYS), Tufin Software Technologies (TUFN), Digimarc (DMRC), Asure Software (ASUR), Travelzoo (TZOO) and Pareteum (TEUM). View all competitors.

What other stocks do shareholders of Nextgen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nextgen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Welltower (WELL), Exxon Mobil (XOM), American Airlines Group (AAL), Best Buy (BBY), British American Tobacco (BTI) and Clorox (CLX).

Who are Nextgen Healthcare's key executives?

Nextgen Healthcare's management team includes the following people:

Mr. John R. Frantz, Pres, CEO & Director (Age 52)
Mr. James Robert Arnold Jr., Exec. VP, CFO & Principal Accounting Officer (Age 63)
Mr. David A. Metcalfe, Exec. VP & Chief Technology Officer (Age 56)
Mr. Jeffrey D. Linton, Exec. VP, Gen. Counsel & Sec. (Age 56)
Mr. Scott E. Bostick, Non-Exec. Officer (Age 54)

What is Nextgen Healthcare's stock symbol?

Nextgen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are Nextgen Healthcare's major shareholders?

Nextgen Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include Brown Capital Management LLC (13.58%), BlackRock Inc. (11.53%), Investment Counselors of Maryland LLC (3.53%), State Street Corp (2.65%), Invesco Ltd. (1.76%) and Geode Capital Management LLC (1.55%). Company insiders that own Nextgen Healthcare stock include George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis and Sheldon Razin. View institutional ownership trends for Nextgen Healthcare.

Which institutional investors are selling Nextgen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Mackay Shields LLC, Brown Capital Management LLC, Morgan Stanley, AQR Capital Management LLC, Martingale Asset Management L P, First Quadrant L P CA, and Alliancebernstein L.P.. View insider buying and selling activity for Nextgen Healthcare.

Which institutional investors are buying Nextgen Healthcare stock?

NXGN stock was acquired by a variety of institutional investors in the last quarter, including Investment Counselors of Maryland LLC, Acadian Asset Management LLC, Matarin Capital Management LLC, State Street Corp, Assenagon Asset Management S.A., Smith Graham & Co. Investment Advisors LP, Wellington Management Group LLP, and Two Sigma Investments LP. Company insiders that have bought Nextgen Healthcare stock in the last two years include James Robert Jr Arnold, Jeffrey D Linton, and Jeffrey H Margolis. View insider buying and selling activity for Nextgen Healthcare.

How do I buy shares of Nextgen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nextgen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $11.27.

How big of a company is Nextgen Healthcare?

Nextgen Healthcare has a market capitalization of $745.00 million and generates $540.24 million in revenue each year. The company earns $24.49 million in net income (profit) each year or $0.59 on an earnings per share basis. Nextgen Healthcare employs 2,660 workers across the globe.

What is Nextgen Healthcare's official website?

The official website for Nextgen Healthcare is www.nextgen.com.

How can I contact Nextgen Healthcare?

Nextgen Healthcare's mailing address is 18111 Von Karman Avenue Suite800, Irvine CA, 92612. The company can be reached via phone at 949-255-2600 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff